Custom Search

Olanzapine News

Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial

Objective: Anorexia nervosa is associated with high mortality, morbidity, and treatment costs. Olanzapine, an atypical antipsychotic, is known to result in weight gain in other patient populations. The objective of this trial was...

Effects of Olanzapine on Slow Wave Sleep, Sleep Spindles and Sleep-Related Memory Consolidation in Schizophrenia

Introduction: Memory deficits and sleep disturbances are common clinical features of schizophrenia. Sleep is supposed to promote memory consolidation and the antipsychotic olanzapine is suggested to improve both sleep and memory...

Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006

OBJECTIVE: This study examined changes in prescribing patterns of antipsychotic medications to treat schizophrenia.

An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia.

OBJECTIVE: To examine the efficacy and tolerability of a new injectable formulation of olanza-pine, olanzapine long-acting injection (LAI), relative to placebo for treatment of acutely ill patients with schizophrenia.

Eli Lilly in Shareholder Cross Hairs

While Eli Lilly’s Zyprexa troubles with the federal government may be coming to an end, the company faces new legal problems with a recent lawsuit filed by two of its company’s shareholders.

Displaying results 1 to 5 out of 25






Next >

Use of this site is subject to the following terms of use